Alkaptonuria- a rare metabolic disorder
Keywords:
Alkaptonuria, homogentisic acid, ochronosis, arthritisAbstract
A 26-year-old male presented with bluish discoloration of both pinnae and history of arthritis for the last few months. Examination showed bluish pigmentation of both pinnae, rest of the examination was unremarkable. Urine examination for the diagnosis of alkaptonuria was positive; however no radiological changes were seen at this stage of the disease. No other systemic abnormality or complication detected.References
Phornphutkul C, Introne WJ, Perry MB et al. Natural history of alkaptonuria. N Engl J Med 2002; 347: 2111-21.
La Du BN. Alkaptonuria. In: Scriver CR, Beaudet AL, Sly WS et al., editors. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: Mcgraw-Hill; 2001. p. 2109-23.
Smith JW. Ochronosis of the sclera and cornea complicating alkaptonuria: review of the literature and report of four cases. JAMA 1942; 120: 1282-7.
Touart DM, Sau P. Cutaneous deposition diseases: part II. J Am Acad Dermatol 1998; 39: 527-44.
Lustberg TJ, Schulman JD, Seegmiller JE. The preparation and identification of various adducts of oxidized homogentisic acid and the development of a new sensitive calorimetric assay for homogentisic acid. Clin Chim Acta 1971; 35: 325-33.
Burtis CA, Ashwood ER, eds. Tietz Textbook of Clinical Chemistry, 3rd edn. Philadelphia: WB Saunders; 1998.
Sealock RR, Gladstone M, Steele JM. Administration of ascorbic acid to an alkaptonuric patient. Proc Soc Exp Biol Med 1940; 44: 580-3.
Mitchell GA, Grompe M, Lambert M, Tanguay RM. Hypertyrosinemia. In: Scriver CR, Beaudet AL, Sly WS et al., eds. The Metabolic and Molecular bases of Inherited Disease, 8th edn. New York: McGraw-Hill; 2001. p.1777-1805.
Eisen D, Hakin MD. Minocyclin-induced pigmentation: incidence, prevention and management. Drug Saf 1998; 18: 431-40.
